RLYB
Income statement / Annual
Last year (2024), Rallybio Corporation's total revenue was $636.00 K,
and the percentage change from the previous year is not available.
In 2024, Rallybio Corporation's net income was -$57.78 M.
See Rallybio Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$636.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$26.34 K
|
| Gross Profit |
$636.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$26.34 K
|
| Gross Profit Ratio |
1
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$41.51 M
|
$53.54 M
|
$40.69 M
|
$26.91 M
|
$17.63 M
|
$11.37 M
|
| General & Administrative Expenses |
$19.63 M
|
$25.39 M
|
$27.20 M
|
$18.74 M
|
$7.67 M
|
$6.28 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$19.63 M
|
$25.39 M
|
$27.20 M
|
$18.74 M
|
$7.67 M
|
$6.28 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$61.13 M
|
$78.93 M
|
$67.88 M
|
$45.65 M
|
$25.30 M
|
$17.64 M
|
| Cost And Expenses |
$61.13 M
|
$78.93 M
|
$67.88 M
|
$45.65 M
|
$25.30 M
|
$17.64 M
|
| Interest Income |
$4.22 M
|
$6.15 M
|
$1.96 M
|
$54.00 K
|
$171.00 K
|
$197.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$10.00 K
|
$49.00 K
|
$39.00 K
|
| Depreciation & Amortization |
$131.00 K
|
$150.00 K
|
$167.00 K
|
$109.00 K
|
$62.00 K
|
$26.34 K
|
| EBITDA |
-$60.37 M |
-$78.78 M |
-$67.72 M |
-$45.39 M |
-$25.24 M |
-$17.39 M |
| EBITDA Ratio |
-94.91
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-95.12
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$2.72 M
|
$4.37 M
|
$155.00 K
|
-$1.37 M
|
-$1.16 M
|
$182.00 K
|
| Income Before Tax |
-$57.78 M
|
-$74.56 M
|
-$67.73 M
|
-$47.01 M
|
-$26.46 M
|
-$17.46 M
|
| Income Before Tax Ratio |
-90.84
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$1.08 M
|
$0.00
|
-$15.00 K
|
$0.00
|
| Net Income |
-$57.78 M
|
-$74.56 M
|
-$66.65 M
|
-$47.01 M
|
-$26.45 M
|
-$17.63 M
|
| Net Income Ratio |
-90.84
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.33 |
-1.84 |
-2.09 |
-1.46 |
-1.19 |
-0.55 |
| EPS Diluted |
-1.33 |
-1.84 |
-2.09 |
-1.46 |
-1.19 |
-0.79 |
| Weighted Average Shares Out |
$43.55 M
|
$40.45 M
|
$31.82 M
|
$32.13 M
|
$22.24 M
|
$22.24 M
|
| Weighted Average Shares Out Diluted |
$43.55 M
|
$40.45 M
|
$31.82 M
|
$32.13 M
|
$22.24 M
|
$22.24 M
|
| Link |
|
|
|
|
|
|
